Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer
Authors
Keywords
TNBC, BIRC6, EGFR signaling, HECTD1, lipid nanoparticles
Journal
Molecular Therapy-Nucleic Acids
Volume 26, Issue -, Pages 798-812
Publisher
Elsevier BV
Online
2021-09-28
DOI
10.1016/j.omtn.2021.09.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applications of lipid nanoparticles in gene therapy
- (2016) Ana del Pozo-Rodríguez et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Nanotechnology: Future of Oncotherapy
- (2015) K. M. Gharpure et al. CLINICAL CANCER RESEARCH
- Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
- (2015) Tingting Hu et al. PLoS One
- Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma
- (2015) Si Zhang et al. Oncotarget
- The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
- (2015) Sze Ue Iris Luk et al. Oncotarget
- BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC6 with p53 facilitating p53 degradation
- (2014) Wenqing Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Expression and clinical significance of BIRC6 in human epithelial ovarian cancer
- (2014) Lin Wang et al. TUMOR BIOLOGY
- Elevated Expression of BIRC6 Protein in Non–Small-Cell Lung Cancers is Associated with Cancer Recurrence and Chemoresistance
- (2013) Xin Dong et al. Journal of Thoracic Oncology
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells
- (2013) Christopher G. Low et al. PLoS One
- Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
- (2012) Fieke Lamers et al. BMC CANCER
- Role of Apollon in Human Melanoma Resistance to Antitumor Agents That Activate the Intrinsic or the Extrinsic Apoptosis Pathways
- (2012) E. Tassi et al. CLINICAL CANCER RESEARCH
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting apoptosis pathways in cancer stem cells
- (2011) Michele Signore et al. CANCER LETTERS
- Comparative Proteomics of Colon Cancer Stem Cells and Differentiated Tumor Cells Identifies BIRC6 as a Potential Therapeutic Target
- (2011) WJ Van Houdt et al. MOLECULAR & CELLULAR PROTEOMICS
- Current prospects for RNA interference-based therapies
- (2011) Beverly L. Davidson et al. NATURE REVIEWS GENETICS
- Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features
- (2010) Ramachandran Venkitaraman Expert Review of Anticancer Therapy
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells
- (2009) Maria Sippel et al. FEBS LETTERS
- Mammosphere‐derived gene set predicts outcome in patients with ER‐positive breast cancer
- (2009) Marleen Kok et al. JOURNAL OF PATHOLOGY
- Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
- (2008) James J. Dignam et al. BREAST CANCER RESEARCH AND TREATMENT
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- IAPs: What's in a Name?
- (2008) Srinivasa M. Srinivasula et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started